Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 112
12
Diseases
99
Unique genes
0.162
Avg. similarity score
Skeletal dysplasia
Most-connected disease (8 links)
Disease
Searched: Dysostosis multiplex, ain-naz type
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Dysostosis multiplex, ain-naz type
Skeletal dysplasia
Larsen syndrome
Bone fragility with contractures, arterial rupture, and deafness
Osteoporosis-pseudoglioma syndrome
Osteogenesis imperfecta
Cole-carpenter syndrome
Skeletal dysplasia, mild, with joint laxity and advanced bone age
Craniotubular dysplasia
Immunoskeletal dysplasia with neurodevelopmental abnormalities
Joint laxity, short stature, and myopia
Spondyloepimetaphyseal dysplasia with joint laxity, 2
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Skeletal dysplasia | 8 | 8 | 42 |
| Larsen syndrome | 6 | 6 | 17 |
| Bone fragility with contractures, arterial rupture, and deafness | 5 | 5 | 49 |
| Osteoporosis-pseudoglioma syndrome | 5 | 5 | 49 |
| Osteogenesis imperfecta | 4 | 4 | 41 |
| Cole-carpenter syndrome | 3 | 3 | 3 |
| Skeletal dysplasia, mild, with joint laxity and advanced bone age | 2 | 2 | 1 |
| Craniotubular dysplasia | 1 | 1 | 1 |
| Dysostosis multiplex, ain-naz type | 1 | 1 | 1 |
| Immunoskeletal dysplasia with neurodevelopmental abnormalities | 1 | 1 | 1 |
| Joint laxity, short stature, and myopia | 1 | 1 | 1 |
| Spondyloepimetaphyseal dysplasia with joint laxity, 2 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| B4GALT7 | 4 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Larsen syndrome, Osteoporosis-pseudoglioma syndrome, Skeletal dysplasia |
| CHST3 | 4 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Larsen syndrome, Osteoporosis-pseudoglioma syndrome, Skeletal dysplasia |
| COL1A1 | 4 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome, Skeletal dysplasia |
| COL1A2 | 4 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome, Skeletal dysplasia |
| CRTAP | 4 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Cole-carpenter syndrome, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| GORAB | 4 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Larsen syndrome, Osteoporosis-pseudoglioma syndrome, Skeletal dysplasia |
| P4HB | 4 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Cole-carpenter syndrome, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| PLOD2 | 4 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome, Skeletal dysplasia |
| SEC24D | 4 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Cole-carpenter syndrome, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| SERPINH1 | 4 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome, Skeletal dysplasia |
| XYLT2 | 4 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Larsen syndrome, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| ALPL | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| B3GALT6 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Larsen syndrome, Osteoporosis-pseudoglioma syndrome |
| B3GAT3 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Larsen syndrome, Osteoporosis-pseudoglioma syndrome |
| BMP1 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| CCDC134 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| CREB3L1 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| CSGALNACT1 | 3 / 12 | Larsen syndrome, Skeletal dysplasia, Skeletal dysplasia, mild, with joint laxity and advanced bone age |
| FKBP10 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| IFITM5 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| KDELR2 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| KIF5B | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| LRP5 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| MBTPS2 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| MESD | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| P3H1 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| P4HA1 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Larsen syndrome, Osteoporosis-pseudoglioma syndrome |
| PHLDB1 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| PLOD3 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Larsen syndrome, Osteoporosis-pseudoglioma syndrome |
| PLS3 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| PPIB | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| SERPINF1 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| SLC10A7 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteoporosis-pseudoglioma syndrome, Skeletal dysplasia |
| SP7 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| SPARC | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| TAPT1 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| TENT5A | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| TMEM38B | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| WNT1 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteogenesis imperfecta, Osteoporosis-pseudoglioma syndrome |
| XYLT1 | 3 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Larsen syndrome, Osteoporosis-pseudoglioma syndrome |
| AMBN | 2 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteoporosis-pseudoglioma syndrome |
| COPB2 | 2 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteoporosis-pseudoglioma syndrome |
| DSPP | 2 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteoporosis-pseudoglioma syndrome |
| EMILIN1 | 2 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteoporosis-pseudoglioma syndrome |
| EXTL3 | 2 / 12 | Immunoskeletal dysplasia with neurodevelopmental abnormalities, Skeletal dysplasia |
| FGFR3 | 2 / 12 | Larsen syndrome, Skeletal dysplasia |
| GZF1 | 2 / 12 | Joint laxity, short stature, and myopia, Larsen syndrome |
| KIF22 | 2 / 12 | Larsen syndrome, Spondyloepimetaphyseal dysplasia with joint laxity, 2 |
| LIFR | 2 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteoporosis-pseudoglioma syndrome |
| LYSET | 2 / 12 | Dysostosis multiplex, ain-naz type, Skeletal dysplasia |
| MIA3 | 2 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteoporosis-pseudoglioma syndrome |
| NBAS | 2 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteoporosis-pseudoglioma syndrome |
| SEC16B | 2 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteoporosis-pseudoglioma syndrome |
| SGMS2 | 2 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteoporosis-pseudoglioma syndrome |
| SUCO | 2 / 12 | Osteogenesis imperfecta, Skeletal dysplasia |
| TMEM53 | 2 / 12 | Craniotubular dysplasia, Skeletal dysplasia |
| WNT11 | 2 / 12 | Bone fragility with contractures, arterial rupture, and deafness, Osteoporosis-pseudoglioma syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Collagen biosynthesis and modifying enzymes | Reactome | 14 / 67 | 25.3× | 1.77e-16 | 6.57e-14 ✓ sig. |
| Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | KEGG | 7 / 21 | 40.4× | 2.21e-10 | 2.24e-8 ✓ sig. |
| Glycosaminoglycan biosynthesis - heparan sulfate / heparin | KEGG | 6 / 24 | 30.3× | 3.21e-8 | 1.99e-6 ✓ sig. |
| ECM proteoglycans | Reactome | 7 / 51 | 16.7× | 1.80e-7 | 8.88e-6 ✓ sig. |
| Non-integrin membrane-ECM interactions | Reactome | 5 / 24 | 25.3× | 1.29e-6 | 4.86e-5 ✓ sig. |
| A tetrasaccharide linker sequence is required for GAG synthesis | Reactome | 5 / 26 | 23.3× | 1.97e-6 | 6.98e-5 ✓ sig. |
| Collagen degradation | Reactome | 6 / 52 | 14.0× | 4.04e-6 | 1.29e-4 ✓ sig. |
| MET activates PTK2 signaling | Reactome | 5 / 30 | 20.2× | 4.16e-6 | 1.32e-4 ✓ sig. |
| Extracellular matrix organization | Reactome | 4 / 15 | 32.4× | 5.53e-6 | 1.66e-4 ✓ sig. |
| Crosslinking of collagen fibrils | Reactome | 4 / 18 | 27.0× | 1.22e-5 | 3.19e-4 ✓ sig. |
| Collagen chain trimerization | Reactome | 5 / 44 | 13.8× | 2.89e-5 | 6.48e-4 ✓ sig. |
| Assembly of collagen fibrils and other multimeric structures | Reactome | 5 / 51 | 11.9× | 5.98e-5 | 1.17e-3 ✓ sig. |
| COPI-dependent Golgi-to-ER retrograde traffic | Reactome | 6 / 99 | 7.4× | 1.63e-4 | 2.60e-3 ✓ sig. |
| Anchoring fibril formation | Reactome | 3 / 15 | 24.3× | 2.30e-4 | 3.41e-3 ✓ sig. |
| ATF6 (ATF6-alpha) activates chaperones | Reactome | 2 / 4 | 60.7× | 3.99e-4 | 5.30e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| collagen fibril organization | GO:0030199 | 15 / 65 | 43.6× | 4.02e-21 | 7.79e-18 ✓ sig. |
| bone mineralization | GO:0030282 | 9 / 56 | 30.3× | 1.40e-11 | 5.30e-9 ✓ sig. |
| ossification | GO:0001503 | 11 / 110 | 18.9× | 1.44e-11 | 5.45e-9 ✓ sig. |
| bone development | GO:0060348 | 9 / 76 | 22.4× | 2.41e-10 | 6.69e-8 ✓ sig. |
| proteoglycan biosynthetic process | GO:0030166 | 6 / 21 | 53.9× | 9.65e-10 | 2.22e-7 ✓ sig. |
| chondroitin sulfate proteoglycan biosynthetic process | GO:0050650 | 6 / 26 | 43.6× | 4.01e-9 | 7.93e-7 ✓ sig. |
| skeletal system development | GO:0001501 | 10 / 151 | 12.5× | 7.41e-9 | 1.36e-6 ✓ sig. |
| heparan sulfate proteoglycan biosynthetic process | GO:0015012 | 6 / 30 | 37.8× | 1.02e-8 | 1.78e-6 ✓ sig. |
| bone morphogenesis | GO:0060349 | 6 / 32 | 35.4× | 1.54e-8 | 2.57e-6 ✓ sig. |
| glycosaminoglycan biosynthetic process | GO:0006024 | 5 / 20 | 47.2× | 5.49e-8 | 7.61e-6 ✓ sig. |
| glycosaminoglycan metabolic process | GO:0030203 | 4 / 12 | 62.9× | 3.55e-7 | 3.61e-5 ✓ sig. |
| cartilage development | GO:0051216 | 7 / 89 | 14.8× | 4.57e-7 | 4.47e-5 ✓ sig. |
| tendon development | GO:0035989 | 3 / 4 | 142× | 5.75e-7 | 5.39e-5 ✓ sig. |
| cementum mineralization | GO:0071529 | 3 / 6 | 94.4× | 2.85e-6 | 1.97e-4 ✓ sig. |
| endoplasmic reticulum to Golgi vesicle-mediated transport | GO:0006888 | 7 / 133 | 9.9× | 6.82e-6 | 3.94e-4 ✓ sig. |